Bal Pharma
₹99.5
-1.95 (-1.92%)
10 May, 2024 00:10 BSE: 524824
NSE: BALPHARMAISIN: INE083D01012
Start SIP in Bal Pharma
Start SIPBal Pharma Performance
Day Range
- Low 98
- High 102
52 Week Range
- Low 81
- High 132
- Open Price101
- Previous Close101
- Volume15632
Bal Pharma Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 81 | 92 | 70 | 82 |
Operating Expenses Qtr Cr | 74 | 85 | 63 | 74 |
Operating Profit Qtr Cr | 8 | 8 | 7 | 8 |
Depreciation Qtr Cr | 3 | 2 | 2 | 2 |
Interest Qtr Cr | 4 | 4 | 4 | 4 |
Tax Qtr Cr | 0 | 1 | 0 | 1 |
Net Profit Qtr Cr | 1 | 2 | 1 | 2 |
Bal Pharma Technicals
EMA & SMA
Current Price
₹99.5
-1.95 (-1.92%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹100.22
- 50 Day
- ₹102.43
- 100 Day
- ₹103.71
- 200 Day
- ₹101.52
- 20 Day
- ₹100.15
- 50 Day
- ₹101.80
- 100 Day
- ₹107.61
- 200 Day
- ₹102.04
Bal Pharma Resistance and Support
PIVOT
₹99.84
Resistance | |
---|---|
First Resistance | 101.57 |
Second Resistance | 103.63 |
Third Resistance | 105.37 |
RSI | 47.81 |
MFI | 64.84 |
MACD Single Line | -0.66 |
MACD | -0.44 |
Support | |
---|---|
First Resistance | 97.77 |
Second Resistance | 96.03 |
Third Resistance | 93.97 |
Bal Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 18,350 | 1,315,512 | 71.69 |
Week | 20,212 | 1,440,321 | 71.26 |
1 Month | 18,899 | 1,284,020 | 67.94 |
6 Month | 82,576 | 4,475,639 | 54.2 |
Bal Pharma Result Highlights
Bal Pharma Synopsis
NSE-Medical-Diversified
Bal Pharma Ltd belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 303.10 Cr. and Equity Capital is Rs. 15.69 Cr. for the Year ended 31/03/2023. Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368.Market Cap | 157 |
Sales | 326 |
Shares in Float | 0.77 |
No of funds | 1 |
Yield | 1 |
Book Value | 1.61 |
U/D Vol ratio | 0.5 |
LTDebt / Equity | 32 |
Alpha | -0.08 |
Beta | 1.48 |
Bal Pharma
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 51.23% | 51.23% | 51.61% | 51.61% |
Foreign Portfolio Investors | 0.13% | 0.13% | 0.14% | 0.17% |
Individual Investors | 32.15% | 32.64% | 32.19% | 31.99% |
Others | 16.49% | 16% | 16.06% | 16.23% |
Bal Pharma Management
Name | Designation |
---|---|
Mr. Shailesh D Siroya | Managing Director |
Mr. Himesh Virupakshaya | Executive Director |
Mr. Jatish Sheth | Independent Director |
Dr. C V Srinivas | Independent Director |
Ms. Nicloa Neeladri | Independent Director |
Mr. H S Venkatesh | Independent Director |
Mr. Kotian Chittananda Damodar | Executive Director |
Bal Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Bal Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-28 | Audited Results & Final Dividend | |
2024-02-12 | Quarterly Results | |
2023-11-08 | Quarterly Results & ESOP | |
2023-08-11 | Quarterly Results & A.G.M. | |
2023-05-29 | Audited Results & Final Dividend |
Bal Pharma FAQs
What is Share Price of Bal Pharma ?
Bal Pharma share price is ₹99 As on 09 May, 2024 | 23:56
What is the Market Cap of Bal Pharma ?
The Market Cap of Bal Pharma is ₹157.3 Cr As on 09 May, 2024 | 23:56
What is the P/E ratio of Bal Pharma ?
The P/E ratio of Bal Pharma is 44.7 As on 09 May, 2024 | 23:56
What is the PB ratio of Bal Pharma ?
The PB ratio of Bal Pharma is 2.5 As on 09 May, 2024 | 23:56